The WSJ reports the Trump administration wants to charge patent holders 1% to 5% of their patent’s value to maintain the patent after grant. If implemented, this would mark a dramatic departure from the traditional flat-fee...more
8/1/2025
/ Administrative Procedure Act ,
Biotechnology ,
Innovation ,
Intellectual Property Protection ,
Medical Devices ,
Patent Fees ,
Patents ,
Pharmaceutical Industry ,
Regulatory Reform ,
Trade Secrets ,
Trump Administration ,
USPTO
The oral argument in the combined Arthrex cases was held on March 1, 2021. While the parties argued what they considered to be the key issues in their merits briefing, the oral argument provided insight into how the justices...more